Literature DB >> 4036699

Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.

G Utermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4036699     DOI： 10.1007/978-1-4613-2459-1_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm.

Authors:  Anastazia Kei; George Miltiadous; Eleni Bairaktari; Marilena Hadjivassiliou; Marios Cariolou; Moses Elisaf
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

2.  LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.

Authors:  Susan J Murdoch; Andrew P Boright; Andrew D Paterson; Bernard Zinman; Michael Steffes; Patricia Cleary; Karen Edwards; Santica S Marcovina; Jonathan Q Purnell; John D Brunzell
Journal:  Atherosclerosis       Date:  2006-06-05       Impact factor: 5.162

Review 3.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.

Authors:  Judes Poirier; Justin Miron; Cynthia Picard; Patrick Gormley; Louise Théroux; John Breitner; Doris Dea
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

4.  Genetic association of apolipoprotein E with age-related macular degeneration.

Authors:  C C Klaver; M Kliffen; C M van Duijn; A Hofman; M Cruts; D E Grobbee; C van Broeckhoven; P T de Jong
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

5.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

6.  APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample.

Authors:  Jaroslav A Hubacek; Anne Peasey; Hynek Pikhart; Petr Stavek; Ruzena Kubinova; Michael Marmot; Martin Bobak
Journal:  Hum Immunol       Date:  2010-01-25       Impact factor: 2.850
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.